Back to Research

Organization profile

Citus

Citus is a Swiss biotechnology startup and ETH Zurich spin-off that specializes in non-invasive skin health analysis. The company uses advanced diagnostic technology and a comprehensive database to provide real-time biological age assessments and personalized skincare solutions for the longevity market.46

Dübendorf, SwitzerlandFounded 2023

Overview

1. Executive Summary (Confidence: Moderate)

CITUS is an emerging high-tech venture in the Swiss longevity ecosystem, founded in 2023 as a spin-off from the prestigious ETH Zurich. The company’s core mission is to provide the world’s most accurate skin health analysis by bridging the gap between non-invasive diagnostics and biological longevity science. CITUS has already demonstrated technical and financial traction, securing CHF 375,000 in convertible loan funding in October 2023 to advance its skin health platform. By offering real-time assessments of biological age through skin biomarkers, the startup empowers both consumers and professional wellness providers to optimize health, beauty, and long-term vitality through data-driven personalization.

Unlock the full profileGet the complete company dossier

This public view only shows an extract. Open the full profile to access the complete company intelligence record, including the full write-up and structured research details.

Desktop only

Research is currently available on desktop only.

The Research module is designed for larger screens. Please reopen it on a desktop or laptop to use the screener, filters, detail pages, and admin tools.